Back to Search
RINI RATAN, M.D.
M.D.
Obstetrics & Gynecology Physician
NPI: 1699702951Individual
Specialties, Licenses & Credentials
Obstetrics & Gynecology PhysicianPrimary
Obstetrics & Gynecology
Code: 207V00000X
227733-1(NY)
Research & Publications (20)
A model for instituting a comprehensive program of remediation for at-risk residents.
PMID 18978119·Obstet Gynecol·2008
8-other
Novel multi-modal strategies to promote brain and spinal cord injury recovery.
PMID 19064774·Stroke·2009
7-preclinical
Small molecule activation of adaptive gene expression: tilorone or its analogs are novel potent activators of hypoxia inducible factor-1 that provide prophylaxis against stroke and spinal cord injury.
PMID 19076458·Ann N Y Acad Sci·2008
7-preclinical
Harnessing hypoxic adaptation to prevent, treat, and repair stroke.
PMID 18043901·J Mol Med (Berl)·2007
6-review
Translation of ischemic preconditioning to the patient: prolyl hydroxylase inhibition and hypoxia inducible factor-1 as novel targets for stroke therapy.
PMID 15472113·Stroke·2004
6-review
HIF prolyl hydroxylase inhibitors prevent neuronal death induced by mitochondrial toxins: therapeutic implications for Huntington's disease and Alzheimer's disease.
PMID 19659431·Antioxid Redox Signal·2010
7-preclinical
Selective inhibition of hypoxia-inducible factor (HIF) prolyl-hydroxylase 1 mediates neuroprotection against normoxic oxidative death via HIF- and CREB-independent pathways.
PMID 19587290·J Neurosci·2009
4-observational
Putting the 'HAT' back on survival signalling: the promises and challenges of HDAC inhibition in the treatment of neurological conditions.
PMID 19388875·Expert Opin Investig Drugs·2009
6-review
Inhibition of prolyl hydroxylase protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity: model for the potential involvement of the hypoxia-inducible factor pathway in Parkinson disease.
PMID 19679656·J Biol Chem·2009
7-preclinical
A nonradioactive dot blot assay for transglutaminase activity.
PMID 19306836·Anal Biochem·2009
7-preclinical
ATF4 is an oxidative stress-inducible, prodeath transcription factor in neurons in vitro and in vivo.
PMID 18458112·J Exp Med·2008
7-preclinical
Antioxidants, HIF prolyl hydroxylase inhibitors or short interfering RNAs to BNIP3 or PUMA, can prevent prodeath effects of the transcriptional activator, HIF-1alpha, in a mouse hippocampal neuronal line.
PMID 18774900·Antioxid Redox Signal·2008
7-preclinical
The BHU bicentric bipolar prosthesis in fracture neck femur in active elderly.
PMID 18817566·J Trauma Manag Outcomes·2008
8-other
Drosophila importin alpha1 performs paralog-specific functions essential for gametogenesis.
PMID 18245351·Genetics·2008
7-preclinical
Mitochondria and oxidative stress in neurodegenerative disorders. Preface.
PMID 19076425·Ann N Y Acad Sci·2008
8-other
Prolyl 4-hydroxylase activity-responsive transcription factors: from hydroxylation to gene expression and neuroprotection.
PMID 17981760·Front Biosci·2008
6-review
Pulse inhibition of histone deacetylases induces complete resistance to oxidative death in cortical neurons without toxicity and reveals a role for cytoplasmic p21(waf1/cip1) in cell cycle-independent neuroprotection.
PMID 18171934·J Neurosci·2008
7-preclinical
Nationwide data confirms absence of 'July phenomenon' in obstetrics: it's safe to deliver in July.
PMID 17262037·J Perinatol·2007
8-other
CD81, a cell cycle regulator, is a novel target for histone deacetylase inhibition in glioma cells.
PMID 17481908·Neurobiol Dis·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 161 FORT WASHINGTON AVE
NEW YORK, NY 10032 - Phone
- (212) 305-2507
Quick Facts
- NPI
- 1699702951
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile